ROSETTA-LUNG-01: Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer (clinicaltrials.gov) - Oct 15, 2026 - P3 | N=621 | Recruiting | Sponsor: BioNTech SE | Trial completion date: Mar 2029 ➔ Jul 2029 | Trial primary completion date: Dec 2028 ➔ Apr 2029
Trial completion date • Trial primary completion date • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
|